New sepsis bundle released
According to an article in Intensive Care Medicine, the Surviving Sepsis Campaign has created the “hour-1 bundle” for managing sepsis to streamline care and…
Web Exclusives
FDA approves new drug for rare form of rickets
On April 17, the U.S. Food and Drug Administration (FDA) approved Crysvita (burosumab), the first drug approved to treat adults and children ages 1…
Sentinel event alert on violence against healthcare workers
On April 16, The Joint Commission released “Sentinel Event Alert 59: Physical and verbal violence against health care workers,” which notes that 25% of…
Alarming stats about alarms
A study in the American Journal of Critical Care finds that compared to an earlier survey, almost twice as many clinicians report that their…
FDA clears AI device for detecting diabetic retinopathy
On April 11, the U.S. Food and Drug Administration (FDA) cleared IDx-DR, the first medical device to use artificial intelligence (AI) to detect greater-than-mild…
Point-of-care testing for HCV
Scientists have developed and validated a rapid, reliable, point-of-care assay for hepatitis C virus (HCV), which will be helpful for countries with limited resources.…
Patient acuity tool on a medical-surgical unit
Use a tool for consistent, objective, and quantifiable patient assignments. Patient assignments can lead to dissatisfaction among nursing staff, especially when they’re not consistent,…
FDA approves new drug for certain types of ALL
On March 29, the U.S. Food and Drug Administration (FDA) approved Blincyto (blinatumomab) to treat adults and children with B-cell precursor acute lymphoblastic leukemia…
CDC: Fighting antibiotic resistance
If you’re looking for ways to better contain bacteria with unusual antibiotic resistance, take a look at suggestions from the Centers for Disease Control…
Self-acupressure app reduces menstrual pain
A smartphone app for self-acupressure reduced menstrual pain, according to a study in the American Journal of Obstetrics & Gynecology. (more…)
New sepsis bundle released
According to an article in Intensive Care Medicine, the Surviving Sepsis Campaign has created the “hour-1 bundle” for managing sepsis to streamline…
FDA approves new drug for rare form of rickets
On April 17, the U.S. Food and Drug Administration (FDA) approved Crysvita (burosumab), the first drug approved to treat adults and children…
Sentinel event alert on violence against healthcare workers
On April 16, The Joint Commission released “Sentinel Event Alert 59: Physical and verbal violence against health care workers,” which notes that…
Alarming stats about alarms
A study in the American Journal of Critical Care finds that compared to an earlier survey, almost twice as many clinicians report…
FDA clears AI device for detecting diabetic retinopathy
On April 11, the U.S. Food and Drug Administration (FDA) cleared IDx-DR, the first medical device to use artificial intelligence (AI) to…
Point-of-care testing for HCV
Scientists have developed and validated a rapid, reliable, point-of-care assay for hepatitis C virus (HCV), which will be helpful for countries with…
Patient acuity tool on a medical-surgical unit
Use a tool for consistent, objective, and quantifiable patient assignments. Patient assignments can lead to dissatisfaction among nursing staff, especially when they’re…
FDA approves new drug for certain types of ALL
On March 29, the U.S. Food and Drug Administration (FDA) approved Blincyto (blinatumomab) to treat adults and children with B-cell precursor acute…
CDC: Fighting antibiotic resistance
If you’re looking for ways to better contain bacteria with unusual antibiotic resistance, take a look at suggestions from the Centers for…
Self-acupressure app reduces menstrual pain
A smartphone app for self-acupressure reduced menstrual pain, according to a study in the American Journal of Obstetrics & Gynecology. (more…)
Test Your Knowledge
Emotional Intel TYK
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.